Clinical Trials

Showing trials with last updates posted in 2026.

NCT06638892 | RECRUITING | NA
1000 participants

Using PrEP, Doing It for Ourselves

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2026-02-13
Completion:
2029-06-30
Conditions
  • HIV Prevention
  • PrEP
Interventions
  • BEHAVIORAL
  • OTHER
No Results Yet
NCT06600191 | RECRUITING | NA
10 participants

Capstan Medical TMVR Study: FIH

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2025-02-24
Completion:
2026-12-31
Conditions
  • Mitral Regurgitation
Interventions
  • DEVICE
No Results Yet
NCT06589804 | RECRUITING | PHASE3
158 participants

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2025-03-27
Completion:
2029-11-30
Conditions
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Hypopharyngeal Squamous Cell Carcinoma
  • Metastatic Laryngeal Squamous Cell Carcinoma
  • Metastatic Oral Cavity Squamous Cell Carcinoma
  • Metastatic Oropharyngeal Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
  • Recurrent Neck Squamous Cell Carcinoma of Unknown Primary
  • Recurrent Oral Cavity Squamous Cell Carcinoma
  • Recurrent Oropharyngeal Squamous Cell Carcinoma
  • Refractory Head and Neck Squamous Cell Carcinoma
  • Refractory Hypopharyngeal Squamous Cell Carcinoma
  • Refractory Laryngeal Squamous Cell Carcinoma
  • Refractory Oral Cavity Squamous Cell Carcinoma
  • Refractory Oropharyngeal Squamous Cell Carcinoma
  • Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage IV Hypopharyngeal Carcinoma AJCC v8
  • Stage IV Laryngeal Cancer AJCC v8
  • Stage IV Lip and Oral Cavity Cancer AJCC v8
  • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT06577025 | ACTIVE_NOT_RECRUITING | PHASE2
43 participants
NCT06548490 | RECRUITING | PHASE2
200 participants

GLP-1R Agonist Treatment for Opioid Use Disorder

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-28
Start Date:
2025-01-27
Completion:
2027-04-30
Conditions
  • Opioid Use Disorder
  • Opioid Abuse and Addiction
  • Narcotic-Related Disorders
  • Substance-Related Disorders
  • Chemically-Induced Disorders
  • Mental Disorder
  • Opioid
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page